Technical Analysis for ENZ - Enzo Biochem, Inc.

Grade Last Price % Change Price Change
grade B 2.91 -3.64% -0.11
ENZ closed down 3.64 percent on Wednesday, June 3, 2020, on 46 percent of normal volume.
Earnings due: Jun 8
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical ENZ trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup -3.64%
20 DMA Support Bullish -3.00%
Pocket Pivot Bullish Swing Setup -3.00%
200 DMA Support Bullish 2.11%
20 DMA Support Bullish 2.11%
1,2,3 Pullback Bullish Bullish Swing Setup 2.11%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.11%
Narrow Range Bar Range Contraction 2.11%
NR7 Range Contraction 2.11%
Doji - Bullish? Reversal 2.11%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Enzo Biochem, Inc., an integrated life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, Life Sciences, and Therapeutics. The Clinical Labs segment offers routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. This segment operates a full-service clinical laboratory, a network of approximately 30 patient service centers, a laboratory, and a full-service phlebotomy and in-house logistics department. The Life Sciences segment manufactures, develops, and markets products and tools to life sciences, drug development, and clinical research customers. It provides proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which offer tools for target identification/validation, high content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis to life science researchers. This segment provides its products to scientific experts primarily in the field of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Therapeutics segment researches and develops therapeutic drug candidates in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. The company sells its products through its direct sales force; and a network of distributors worldwide. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.
Biotechnology Cancer Life Sciences Diabetes Antibodies Obesity Drug Development Gene Expression Neurological Disorders Genetic Engineering Cardiovascular Disease Two River Metabolic Diseases Medical Laboratory Medical Diagnosis Endocrine Disorders

Is ENZ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 4.85
52 Week Low 1.56
Average Volume 694,861
200-Day Moving Average 2.81
50-Day Moving Average 2.65
20-Day Moving Average 2.86
10-Day Moving Average 2.98
Average True Range 0.25
ADX 33.5
+DI 28.48
-DI 14.10
Chandelier Exit (Long, 3 ATRs ) 2.53
Chandelier Exit (Short, 3 ATRs ) 3.14
Upper Bollinger Band 3.20
Lower Bollinger Band 2.52
Percent B (%b) 0.58
BandWidth 23.91
MACD Line 0.09
MACD Signal Line 0.10
MACD Histogram -0.01
Fundamentals Value
Market Cap 135.45 Million
Num Shares 46.5 Million
EPS -0.05
Price-to-Earnings (P/E) Ratio -58.20
Price-to-Sales 4.40
Price-to-Book 5.34
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.17
Resistance 3 (R3) 3.19 3.12 3.12
Resistance 2 (R2) 3.12 3.06 3.11 3.11
Resistance 1 (R1) 3.02 3.02 2.99 3.00 3.09
Pivot Point 2.95 2.95 2.94 2.94 2.95
Support 1 (S1) 2.85 2.89 2.82 2.83 2.73
Support 2 (S2) 2.78 2.85 2.77 2.71
Support 3 (S3) 2.68 2.78 2.70
Support 4 (S4) 2.66